Mar 25, 2022

Featuring perspectives from Dr Rebecca Olin, including the following topics:

• Introduction: Journal Club with Rebecca L Olin, MD, MSCE — Evaluation of the older patient with acute myeloid leukemia (AML) (0:00)
• Case: A woman in her late 80s with transfusion-dependent AML secondary to myelodysplastic syndrome — Raman Sood, MD (7:52)
• Case: A frail man in his mid 70s with newly diagnosed poor-risk AML with FLT3-ITD and IDH1 mutations — Amany R Keruakous, MD, MS (12:46)
• Case: A woman in her late 60s with relapsed AML and a FLT3-ITD mutation — Prashant Sharma, MD (18:23)
• Case: A man in his late 50s with AML receives 7 + 3 induction prior to discovery of complex cytogenetics — Rachel J Cook, MD (22:04)
• ASH 2021 review — Part 1 (25:07)
• Case: A man in his early 70s with relapsed AML and an IDH2 mutation — Erik J Rupard, MD (29:13)
• Case: A man in his late 50s with therapy-related AML and an IDH2 mutation — Bhavana (Tina) Bhatnagar, DO (32:28)
• Case: A woman in her mid 40s with newly diagnosed poor-risk AML and an ejection fraction of 35% — Dr Keruakous (32:28)
• ASH 2021 review — Part 2 (39:28)
• Faculty survey (58:32)

CME information and select publications